Exercise Levels and Preferences in Cancer Patients: A Cross-Sectional Study.
adherence
cancer
exercise
health promotion
preferences
Journal
International journal of environmental research and public health
ISSN: 1660-4601
Titre abrégé: Int J Environ Res Public Health
Pays: Switzerland
ID NLM: 101238455
Informations de publication
Date de publication:
24 07 2020
24 07 2020
Historique:
received:
07
06
2020
revised:
20
07
2020
accepted:
22
07
2020
entrez:
30
7
2020
pubmed:
30
7
2020
medline:
2
12
2020
Statut:
epublish
Résumé
Despite the benefits related to physical exercise, large numbers of cancer patients are not sufficiently active. To investigate exercise levels and preferences in cancer patients, a cross-sectional study was conducted on a random sample of 392 cancer outpatients who anonymously completed a questionnaire investigating general and medical characteristics, and expressed willingness to participate in exercise programs. Current exercise levels were estimated with the Leisure Score Index (LSI). Most patients (93%) were insufficiently active but 80% declared an interest in exercise programs. Patients preferred oncologist-instructed programs and specified particular exercise needs. Multivariate logistic regression showed that willingness to exercise was associated with education (OR: 1.87; 95% CI: 1.15-3.04 beyond age 14 years vs. up to 14 years) and current physical activity (OR: 1.92; 95% CI: 1.92-3.63 for sweat-inducing activity >2 times/week vs. <1 time/week). Patients given chemotherapy were less inclined to exercise (OR: 0.45; 95% CI: 0.23-0.86) than those who did not. LSI was lower if cancer stage was advanced (β: -0.36; 95% CI: -0.75 to -0.02) than if it was in remission. High LSI was also associated with longer education, lower BMI, and longer time after diagnosis. Cancer patients are insufficiently active but are willing to participate in personalized exercise programs. Information from this survey may help in designing personalized interventions so these patients will achieve sufficient exercise.
Sections du résumé
BACKGROUND
Despite the benefits related to physical exercise, large numbers of cancer patients are not sufficiently active.
METHODS
To investigate exercise levels and preferences in cancer patients, a cross-sectional study was conducted on a random sample of 392 cancer outpatients who anonymously completed a questionnaire investigating general and medical characteristics, and expressed willingness to participate in exercise programs. Current exercise levels were estimated with the Leisure Score Index (LSI).
RESULTS
Most patients (93%) were insufficiently active but 80% declared an interest in exercise programs. Patients preferred oncologist-instructed programs and specified particular exercise needs. Multivariate logistic regression showed that willingness to exercise was associated with education (OR: 1.87; 95% CI: 1.15-3.04 beyond age 14 years vs. up to 14 years) and current physical activity (OR: 1.92; 95% CI: 1.92-3.63 for sweat-inducing activity >2 times/week vs. <1 time/week). Patients given chemotherapy were less inclined to exercise (OR: 0.45; 95% CI: 0.23-0.86) than those who did not. LSI was lower if cancer stage was advanced (β: -0.36; 95% CI: -0.75 to -0.02) than if it was in remission. High LSI was also associated with longer education, lower BMI, and longer time after diagnosis.
CONCLUSION
Cancer patients are insufficiently active but are willing to participate in personalized exercise programs. Information from this survey may help in designing personalized interventions so these patients will achieve sufficient exercise.
Identifiants
pubmed: 32722265
pii: ijerph17155351
doi: 10.3390/ijerph17155351
pmc: PMC7432474
pii:
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Références
Int J Behav Med. 2019 Oct;26(5):499-511
pubmed: 31441015
Am J Public Health. 1995 May;85(5):706-10
pubmed: 7733433
World Health Organ Tech Rep Ser. 1995;854:1-452
pubmed: 8594834
Support Care Cancer. 2018 Nov;26(11):3711-3719
pubmed: 29740694
Crit Rev Oncol Hematol. 2013 Dec;88(3):573-93
pubmed: 23932804
Oncol Nurs Forum. 1988 Jul-Aug;15(4):447-50
pubmed: 3399417
Ann Behav Med. 2008 Feb;35(1):116-22
pubmed: 18347912
Public Health Rep. 1985 Mar-Apr;100(2):126-31
pubmed: 3920711
Med Sci Sports Exerc. 2008 Jun;40(6):1180-7
pubmed: 18460985
J Clin Oncol. 2013 Mar 1;31(7):876-85
pubmed: 23341510
J Behav Med. 2016 Jun;39(3):511-8
pubmed: 26801339
Med Oncol. 2011 Sep;28(3):753-65
pubmed: 20411366
Cancer Pract. 2002 Jul-Aug;10(4):208-15
pubmed: 12100105
Support Care Cancer. 2017 Jul;25(7):2297-2304
pubmed: 28258503
Oncologist. 2017 Oct;22(10):1238-1249
pubmed: 28698390
Support Care Cancer. 2012 Aug;20(8):1709-17
pubmed: 21947412
Support Care Cancer. 2017 Mar;25(3):983-999
pubmed: 27900549
Int J Behav Nutr Phys Act. 2018 Jun 7;15(1):48
pubmed: 29879993
Med Sci Sports Exerc. 2019 Nov;51(11):2375-2390
pubmed: 31626055
Psychol Health Med. 2018 Feb;23(2):224-231
pubmed: 28635312
Med Sci Sports Exerc. 2010 Jul;42(7):1409-26
pubmed: 20559064
Int J Behav Nutr Phys Act. 2016 Sep 09;13(1):100
pubmed: 27612561
Int J Behav Nutr Phys Act. 2014 Jul 06;11:85
pubmed: 24997476
Eur Urol. 2016 Oct;70(4):576-585
pubmed: 26774959
Eur J Cancer Care (Engl). 2006 Mar;15(1):34-43
pubmed: 16441675
J Behav Med. 2012 Oct;35(5):492-9
pubmed: 21877174
Cancer Nurs. 2012 Jul-Aug;35(4):312-22
pubmed: 22228393
Can J Appl Sport Sci. 1985 Sep;10(3):141-6
pubmed: 4053261
Oncol Nurs Forum. 2013 Jan;40(1):44-52
pubmed: 23269769
Eur J Cancer Care (Engl). 2011 Jan;20(1):96-105
pubmed: 20345456
Medicine (Baltimore). 2016 Oct;95(40):e4629
pubmed: 27749527
Support Care Cancer. 2014 Feb;22(2):495-502
pubmed: 24091722
Clin Otolaryngol. 2012 Oct;37(5):390-2
pubmed: 23164265
BMC Med Res Methodol. 2015 Aug 12;15:60
pubmed: 26264621
Med Sci Sports Exerc. 2008 Jul;40(7 Suppl):S512-8
pubmed: 18562968
Cancer Nurs. 2020 May/Jun;43(3):E132-E158
pubmed: 32000174
Support Care Cancer. 2015 Aug;23(8):2407-16
pubmed: 25605568
Br J Sports Med. 2018 Apr;52(8):505-513
pubmed: 28954800
J Cancer Surviv. 2007 Mar;1(1):27-34
pubmed: 18648942
Arch Phys Med Rehabil. 2018 Dec;99(12):2621-2636
pubmed: 29730319
Psychooncology. 2017 May;26(5):664-671
pubmed: 26818101
Phys Ther. 2010 Aug;90(8):1135-47
pubmed: 20558566
Br J Cancer. 2016 Nov 22;115(11):1304-1312
pubmed: 27811855
Front Psychol. 2016 Jun 21;7:898
pubmed: 27445882
J Pain Symptom Manage. 2017 Aug;54(2):245-258.e2
pubmed: 28533160
Psychooncology. 2009 Apr;18(4):412-21
pubmed: 19241491
Clin J Oncol Nurs. 2012 Jun 1;16(3):E84-98
pubmed: 22641333
Head Neck. 2009 Aug;31(8):994-1005
pubmed: 19340875
Psychooncology. 2009 Apr;18(4):422-8
pubmed: 19243089
Psychooncology. 2017 Nov;26(11):1901-1906
pubmed: 27530961
J Physiother. 2016 Apr;62(2):68-82
pubmed: 26996098
Cancer Nurs. 2006 Jul-Aug;29(4):259-65
pubmed: 16871091
Support Care Cancer. 2015 Nov;23(11):3239-47
pubmed: 25832895
J Clin Oncol. 2018 Aug 1;36(22):2297-2305
pubmed: 29894274
J Cancer Res Clin Oncol. 2018 Jan;144(1):1-12
pubmed: 29210001
Psychooncology. 2018 Mar;27(3):713-724
pubmed: 29247584
Cancer Treat Rev. 2017 Jan;52:91-104
pubmed: 28006694
Cancer Med. 2019 Aug;8(9):4497-4507
pubmed: 31207165